People
How Abhinava Sikdar Is Helping Investors Enhance Value in Energy Infrastructure
A new breed of specialists is emerging to help investors better understand and optimize value beyond the traditional buy-and-hold strategy. Among them is commodities quant Abhinava Sikdar.
Ukraine: A Worrying Asymmetry in Precision Strikes
July 2025 has proven to be a critical juncture in the Ukraine-Russia war. Russia has intensified its targeting of Ukrainian ammunition depots, supply chains, and critical military infrastructure hubs, multiplying Deep Precision Strikes (DPS).
Beyond Housing as a Blueprint: Cross-Sector Collaboration for Scalable Social Impact
Beyond Housing's portfolio includes more than 800 rental units as well as commercial and retail properties, a health center, entertainment and hospitality venues, and more. The secret to Beyond Housing's significant, scalable social impact is cross-sector collaboration.
What Grand Pharma Reveals About the Risks of Foreign Investment in U.S. Life Sciences Startups
Cross-border licensing and biotech partnership deals with Chinese firms have surged in recent years, reshaping the global life sciences landscape. Amid this surge, one player has been especially active: Grand Pharmaceutical Group Limited—known as Grand Pharma—a Hong Kong–listed pharmaceutical group with roots in mainland China.

















